NCT03942666View on ClinicalTrials.gov

PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

November 22, 2019

Study Completion Date

November 22, 2019

Conditions
Asthma
Interventions
DRUG

Treatment A

tablet of CHF 6532

DRUG

Treatment B

tablet of CHF 6532

DRUG

Treatment C

tablet of CHF 6532

DRUG

Treatment D

tablet of CHF 6532

DRUG

Treatment E

Placebo tablet of CHF 6532

DRUG

Treatment F

tablet of CHF 6532

Trial Locations (1)

2060

SGS Life Sciences - Clinical Pharmacology Unit Antwerpen, Antwerp

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT03942666 - PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects | Biotech Hunter | Biotech Hunter